AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹254 Cr | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹254 Cr |
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹359 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹70 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹254 Cr | 3.66 | |
| Mar2025 | ₹245 Cr | -31.86 | |
| Mar2024 | ₹359 Cr | 169.22 | |
| Mar2023 | ₹133 Cr | 89.34 | |
| Mar2022 | ₹70 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,633.9 Cr | 12.7% | 26.6% | -1.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | 12.7% |
26.6% |
-1.9% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses